BRPI0916230A2 - rna antagonists targeting gli2 - Google Patents
rna antagonists targeting gli2Info
- Publication number
- BRPI0916230A2 BRPI0916230A2 BRPI0916230A BRPI0916230A BRPI0916230A2 BR PI0916230 A2 BRPI0916230 A2 BR PI0916230A2 BR PI0916230 A BRPI0916230 A BR PI0916230A BR PI0916230 A BRPI0916230 A BR PI0916230A BR PI0916230 A2 BRPI0916230 A2 BR PI0916230A2
- Authority
- BR
- Brazil
- Prior art keywords
- gli2
- antagonists targeting
- rna antagonists
- targeting gli2
- rna
- Prior art date
Links
Abstract
"antagonistas de rna que tem como alvo a gli2" a presente invenção refere-se aos compostos de oligômero (oligômeros), que alvejam mrna de gli2 em uma célula, levando a uma reduzida expressão de gli2. a redução de expressão de gli2 é benéfica para o tratamento de determinados distúrbios médicos, como distúrbios hiperproliferativos, como câncer.The present invention relates to oligomer compounds (oligomers) which target gli2 mRNA in a cell, leading to reduced expression of gli2. Gli2 expression reduction is beneficial for the treatment of certain medical disorders such as hyperproliferative disorders such as cancer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08104754 | 2008-07-15 | ||
US8113508P | 2008-07-16 | 2008-07-16 | |
PCT/IB2009/006407 WO2010007522A1 (en) | 2008-07-15 | 2009-07-15 | Rna antagonists targeting gli2 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0916230A2 true BRPI0916230A2 (en) | 2019-04-16 |
Family
ID=67251416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0916230A BRPI0916230A2 (en) | 2008-07-15 | 2009-07-15 | rna antagonists targeting gli2 |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0916230A2 (en) |
-
2009
- 2009-07-15 BR BRPI0916230A patent/BRPI0916230A2/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010005703A (en) | Lna antagonists targeting the androgen receptor. | |
MX2018012038A (en) | Modified rnai agents. | |
UA115983C2 (en) | Dna-pk inhibitors | |
BR112012030699A2 (en) | Methods To Treat Bladder Cancer | |
MX2010006039A (en) | Rna antagonist compounds for the modulation of pik3ca expression. | |
MX2019002917A (en) | Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma. | |
MD20150043A2 (en) | Inhibitors of histone demethylases | |
BR112015000399A2 (en) | pyrazolyl pyrimidine derivatives | |
CU20110168A7 (en) | BENZOFURANILO DERIVATIVES | |
IN2012DN02081A (en) | ||
CL2009001151A1 (en) | Compounds derived from benzomorphane alicyclic carbocyclic acids, preparation procedure, pharmaceutical composition, useful for treating diseases influenced by the inhibition of the enzyme 11beta-hydroxysteroid dehydrogenase, such as metabolic disorders. | |
MX2009011878A (en) | Rna antagonist compounds for the modulation of beta-catenin. | |
MX346147B (en) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use. | |
NZ607996A (en) | Substituted nucleotide analogs | |
MY166026A (en) | Tetrahydro-pyrido-pyrimidine derivatives | |
BR112014026801A2 (en) | 5 - [[4 - [[morpholin-2-yl] methylamino] -5- (trifluoromethyl) -2-pyridyl] amino] pyrazine-2-carbonitrile and therapeutic uses thereof | |
UY33246A (en) | TIENOPIRIMIDINES CONTAINING CYCLLOQUAL FOR PHARMACEUTICAL COMPOSITIONS | |
WO2010007522A8 (en) | Rna antagonists targeting gli2 | |
BR112014021612A2 (en) | compositions and methods for modulating atxn3 expression | |
MX2015006289A (en) | Compositions and methods for modulation of fgfr3 expression. | |
MX2011009493A (en) | Compounds for the treatment of metabolic disorders. | |
MX337849B (en) | Compositions and methods for inhibition of the jak pathway. | |
MX349550B (en) | 1, 7 - diazacarbazoles and their use in the treatment of cancer. | |
BR112015029504A2 (en) | kinase inhibitors | |
BR112012013918A2 (en) | diacyl glycerol acyl transferase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2520 DE 25-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |